Michael A. London
Phone: 212-566-7500 x 209
Michael A. London is one of the founding partners of the law firm Douglas & London, P.C., located in downtown New York City. Mr. London obtained my Bachelor of Arts degree from the University of Miami in Coral Gables, Florida, and his Juris Doctor degree from Brooklyn Law School in Brooklyn, New York. Mr. London is admitted and licensed to practice law in the States of New York and New Jersey, as well as in the United States District Courts for the Eastern District, Southern District, and Western District of New York, as well as the District of New Jersey.
Since obtaining his law degree, he has devoted his entire career to representing consumers and injury victims, primarily in mass tort settings. His practice area in the law has always focused on, and continues to focus on, products liability and complex litigation with an emphasis on pharmaceutical and medical device litigation.
Mr. London has been privileged to have been appointed to, and have served, as lead or liaison counsel on numerous Plaintiffs’ Steering Committees in some of the largest national mass tort and complex litigations in recent years. His formal lead and liaison counsel roles have been in the following matters with the following results:
- Vice-Chair of Plaintiffs’ Steering Committee – In re: Zyprexa Products Liability Litigation, MDL-1596, before the Honorable Jack B. Weinstein in the United States District Court for the Eastern District of New York (status: resolved, $700 million settlement of approximately 8,000 claims);
- Co-Lead Counsel of Plaintiffs’ Steering Committee – In re: Yasmin and Yaz (Drospirenone) Marketing Sales Practices and Products Liability Litigation, MDL-2100, before the Honorable David R. Herndon in the United States District Court for the Southern District of Illinois (status: over 99.99% of the over 17,000 claims resolved through individual and mass semi-confidential settlements of claims in federal and state courts with the defendants paying over $2 billion);
- Co-Lead Counsel and Liaison Counsel for Plaintiffs’ Steering Committee – In re: Bayer Corp. Combination Aspirin Products Marketing and Sales Practice Litigation, MDL-2023, before the Honorable Brian M. Cogan in the United States District Court for the Eastern District of New York (status: resolved, $15 million class settlement);
- Co-Lead Counsel of Plaintiffs’ Steering Committee – In re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation, MDL-2385, before the Honorable David R. Herndon in the United States District Court for the Southern District of Illinois (status: resolved, $650 million settlement of approximately 4,000 claims);
- Liaison Counsel and Plaintiffs’ Executive Committee Member – In re: Ortho Evra Products Liability Litigation, MDL-1742, before the late Honorable David S. Katz in the United States District Court for the Northern District of Ohio (status: resolved, individual confidential settlements of approximately 3,000 claims in federal and state courts);
- Co-Liaison Counsel for all Plaintiffs – In re: Levaquin Litigation, centralized and consolidated litigation before the late Honorable Carol E. Higbee in the Superior Court of New Jersey, Atlantic County (status: resolved, individual confidential settlements of hundreds of claims in federal and state courts); and
- Co-Lead Counsel of Plaintiffs’ Steering Committee – In re: E.I. du Pont de Nemours and Company C-8 Personal Injury Litigation, MDL-2433, before the Honorable Edmund A. Sargus, Jr., pending in the United States District Court for the Southern District of Ohio (status: resolved, $671 million settlement of approximately 3,600 claims).
- Co-Lead Counsel of Plaintiffs’ Steering Committee – In re: Invokana (Canagliflozin) Products Liability Litigation, MDL-2750, before the Honorable Brian Martinotti in the United States District Court for the District of New Jersey, (status: resolutions pending via individual confidential settlements of approximately 2,000 claims).
It is also important to highlight, that in the eight litigations in which Mr. London served in a heightened role as co-lead or liaison counsel, each was resolved efficiently through overall settlements. And in these eight national mass tort or class litigations where Mr. London held leadership appointments, the resolutions were accomplished in an impressive span of 18 to 47 months from when MDL centralization occurred until announcement of settlement parameters. From the settlements above, Mr. London has personally served as a primary negotiator for plaintiffs in what has yielded over $2 billion worth of settlements since 2005.
Not only has he held the court-appointed positions as set forth above but he has also been involved in other complex litigations in various committee roles, including serving on discovery committees, expert committees, law and briefing committees, and class action committees. I have represented hundreds of women exposed in utero to the drug Diethylstilbestrol (“
Mr. London served as trial counsel in multiple tobacco trials, including the first successful verdict against the tobacco industry in the state of New York, where he and law firm partner, Gary Douglas, secured a $20 million-plus verdict for the widow of a former smoker. And before that, Mr. London served as co-trial counsel in the first two tobacco cases to be tried in the State of New York – both in the year 2000. Mr. London was co-trial counsel in the very first Norplant products liability trial in the State of New York – and shortly after the verdict in his trial, a national settlement of over $40 million was reached.
Mr. London is an active member in the following legal associations: Board of Directors and Executive Committee Member of New York State Trial Lawyers Association (NYSTLA); Board of Governors and Sustaining Member American Association of Justice (AAJ); Member of Public Justice (America’s Public Interest law firm); and Member the Tobacco Trial Lawyers Association (TTLA). He serves on the President’s Advisory Council at Brooklyn Law School. He has been asked and invited to lecture to attorneys on many types of cases that he has handled, as well as on specific topics such as preemption, virtually all aspects of mass tort litigations and specific mass tort cases, medical malpractice and jury selection in various types of cases. He has appeared on CNN, MSNBC, NBC, ABC, in the New York Times, in New York Magazine, Forbes, as well as in many other local New York and regional papers and other publications across the country. Additionally, he has written numerous articles for publication in legal journals on such topics of vaccine use, the Learned Intermediary Doctrine, jury selection in products liability cases, mercury exposure, youth smoking, and light cigarettes litigation, generally. In addition, Mr. London is the attorney in charge of Douglas & London’s New Jersey Practice. Further, Mr. London also serves as the firm's general counsel.
 Mr. London has also been asked to serve and have been formally appointed to sit on Plaintiffs’ Steering Committees or Executive Committees (without elevated roles as lead or liaison counsel) in the following cases: In re: Testosterone Replacement Therapy Products Liability Litigation, MDL 2545, pending in the United States District Court, Northern District of Illinois, Mr. London served as chairperson of the Executive Committee of the Plaintiff Steering Committee (status: five of the five product manufacturing defendants have resolved the approximately 7,000 claims against them in the MDL). In the following litigations Mr. London was simply a Court-appointed member of the general Plaintiff Steering Committee; In re: Kugel Mesh Hernia Patch Products Liability Litigation, MDL-1842, pending in the United States District Court of Rhode Island (status: resolved); In re: Heparin Products Liability Litigation, MDL-1953, pending in the United States District Court for the Northern District of Ohio (status: resolved); In re: Imagitas Inc. Drivers’ Privacy Protection Act Litigation, MDL-1828, pending in the United States District Court for the Middle District of Florida (status: resolved); In re: Light Cigarettes Marketing and Sales Practices Litigation, MDL-2068, pending in the United States District Court for the District of Maine (status: resolved); In re: Bextra/Celebrex Products Liability Litigation, pending in the New York State Supreme Court (status: resolved); In re: Zimmer NexGen Knee Implant Products Liability Litigation, MDL-2272, pending in the United States District Court for the Northern District of Illinois, Eastern Division (status: resolved); In re: Denture Cream Products Liability Litigation, MDL-2051, pending in the United States District Court for the Southern District of Florida (status: resolved); and In re: DePuy Orthopaedics, Inc.,
"Since the inception of the firm, Douglas & London has taken the opportunity to give back to the community. It is a right, a privilege and a responsibility our firm takes very seriously. We fully understand that without community, there’s no Douglas & London."-- The Team at Douglas & London